Preferential activity of wild-type and mutant tumor necrosis factor-α against tumor-derived endothelial-like cells

Japanese Journal of Cancer Research

Volumn 91, Issue 1, 2000, Pages 59-67

  Kuroda, Kensei ^a   Miyata, Keizo ^a   Tsutsumi, Yasuo ^b   Tsunoda, Shinichi ^b   Nishimura, Koji ^a   Mitsuishi, Yachiyo ^a   Nakagawa, Shinsaku ^b   Mayumi, Tadanori ^b  

^a ISHIHARA SANGYO KAISHA LTD   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

F4614; TNF mutant RGD V29; TNF ; Tumor vascular targeting; Tumor derived endothelial cells

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DIPLOIDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0034094640     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00860.x     Document Type: Article

References (32)

1. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72, 3666-3670 (1975).
2. Eggermont, A. M. M. Koops, H. S., Lienard, D., Kroon, B. B. R., Van Geel, A. N., Hoekstra, H. J. and Lejeune, F. J. Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J. Clin. Oncol., 14, 2653-2665 (1996).
3. Renard, N., Nooijen, P. T. G. A., Schalkwijk, L., DeWaal, R. M. W., Eggermont, A. M. M., Lienard, D., Kroon, B. B. R., Lejeune, F. J. and Ruiter, D. J. VWF release and platelet aggregation in human melanoma after perfusion with TNFα. J. Pathol., 176, 279-287 (1995).
4. Tracey, K. J., Butler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., III, Zentella, A., Albert, J. D., Shires, G. T. and Cerami, A. Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474 (1986).
5. Shikama, H., Miyata, K., Sakae, N., Kuroda, K., Nishimura, K., Yotsuya, S. and Kato, M. A novel mutein of TNFα containing the Arg-Gly-Asp sequence shows reduced toxicity in intestine. Mediators Inflammation, 3, 111-116 (1994).
6. Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei, E., III and Kufe, D. W. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J. Natl. Cancer Inst., 80, 1039-1044 (1988).
7. Renard, N., Lienard, D., Lespangnard, L., Eggermont, A., Heimann, R. and Lejeune, F. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα). Int. J. Cancer, 57, 656-663 (1994).
8. Tsutsumi, Y., Kihira, T., Tsunoda, S., Kanamori, T., Nakagawa, S. and Mayumi, T. Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumor potency. Br. J. Cancer, 71, 963-968 (1995).
9. Tsutsumi, Y., Tsunoda, S., Kamada, H., Kihira, T., Nakagawa, S., Kaneda, Y., Kanamori, T. and Mayumi, T. Molecular design of hybrid tumour necrosis factor-α. II. The molecular size of polyethylene glycol-modified tumour necrosis factor-α affects its anti-tumour potency. Br. J. Cancer, 74, 1090-1095 (1996).
10. Tsutsumi, Y., Kihira, T., Tsunoda, S., Kamada, H., Nakagawa, S., Kaneda, Y., Kanamori, T. and Mayumi, T. Molecular design of hybrid tumour necrosis factor-α. III. Polyethylene glycol-modified tumor necrosis factor-α has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation. J. Pharmacol. Exp. Ther., 278, 1006-1011 (1996).
11. Kuroda, K., Miyata, K., Shikama, H., Kawagoe, T., Nishimura, K., Takeda, K., Sakae, N. and Kato, M. Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in mice. Int. J. Cancer, 63, 152-157 (1995).
12. Tartaglia, L. A., Ayres, T. M., Wong, G. H. W. and Goeddel, D. V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74, 845-853 (1993).
13. Shikama, H., Miyata, K., Sakae, N., Mitsuishi, Y., Nishimura, K., Kuroda, K. and Kato, M. Novel mutein of tumor necrosis factor α (F4614) with reduced hypotensive effect. J. Interferon Cytokine Res., 15, 677-684 (1995).
14. Utoguchi, N., Dantakean, A., Makimoto, H., Wakai, Y., Tsutsumi, Y., Nakagawa, S. and Mayumi, T. Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma. Jpn. J. Cancer Res., 86, 193-201 (1995).
15. Underwood, J. C. E. and Carr, I. The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma. J. Pathol., 107, 157-166 (1972).
16. Dvorak, H. F., Nagy, J. A., Dvorak, J. T. and Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133, 95-109 (1988).
17. Wu, N. Z., Klitzman, B., Dodge, R. and Dewhirst, M. W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res., 52, 4265-4268 (1992).
18. Fukumura, D., Salehi, H. A., Witwer, B., Tuma, R. F., Melder, R. J. and Jain, R. K. Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site and host strain. Cancer Res., 55, 4824-4829 (1995).
19. Utoguchi, N., Mizuguchi, H., Dantakean, A., Makimoto, H., Wakai, Y., Tsutsumi, Y., Nakagawa, S. and Mayumi, T. Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br. J. Cancer, 73, 24-28 (1996).
20. Utoguchi, N., Mizuguchi, H., Saeki, K., Ikeda, K., Tsutsumi, Y., Nakagawa, S. and Mayumi, T. Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer. Cancer Lett., 89, 7-14 (1995).
21. Jaffe, E. A., Nachman, R. L., Becker, C. G. and Minick, C. R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest., 52, 2745-2756 (1973).
22. Miyata, K., Kato, M., Shikama, H., Nishimura, K., Sakae, N., Kawagoe, K., Nishikawa, T., Kuroda, K., Yamaguchi, K., Aoyama, Y., Mitsuishi, Y. and Yamada, N. A YIGSR-containing novel mutein without the detrimental effect of human TNF-α of enhancing experimental pulmonary metastasis. Clin. Exp. Metastasis, 10, 267-272 (1992).
23. Siflinger-Birnboim, A., Der Vecchio, P. J., Cooper, J. A., Blumenstock, F. A., Shepard, J. M. and Malik, A. B. Molecular sieving characteristics of the cultured endothelial monolayer. J. Cell. Physiol., 132, 111-117 (1987).
24. Miyata, K., Mitsuishi, Y., Shikama, H., Kuroda, K., Nishimura, K., Sakae, N. and Kato, M. Overcoming the metastasis-enhancing potential of human tumor necrosis factor α by introducing the cell-adhesive Arg-Gly-Asp sequence. J. Interferon Cytokine Res., 15, 161-169 (1995).
25. Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol., 11, 767-804 (1993).
26. Watanabe, N., Niitsu, Y., Umeno, H., Kuriyama, H., Neda, H., Yamauchi, N., Maeda, M. and Urushizaki, I. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res., 48, 2179-2183 (1988).
27. Sherman, M. L., Spriggs, D. R., Arthur, K. A., Imamura, K., Frei, E., III and Kufe, D. W. Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J. Clin. Oncol. 6, 344-350 (1988).
28. Brooks, P. C., Clark, R. A. F. and Cheresh, D. A. Requirement of vascular integrin α,β, for angiogenesis. Science, 264, 569-571 (1994).
29. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. Integrin α,β, antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157-1164 (1994).
30. Wang, C.-Y., Mayo, M. W. and Baldwin, A. S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 274, 784-787 (1996).
31. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science, 274, 787-789 (1996).
32. Liu, Z.-G., Hsu, H., Goeddel, D. V. and Karin, M. Dissection of TNF receptor I effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87, 565-576 (1996).